| Literature DB >> 23795283 |
Lisheng Deng1, Li Zhang, Yuan Yao, Cong Wang, Michele S Redell, Shuo Dong, Yongcheng Song.
Abstract
Histone methyltransferase DOT1L is a drug target for MLL leukemia. We report an efficient synthesis of a cyclopentane-containing compound that potently and selectively inhibits DOT1L (Ki = 1.1 nM) as well as H3K79 methylation (IC50 ~ 200 nM). Importantly, this compound exhibits a high stability in plasma and liver microsomes, suggesting it is a better drug candidate.Entities:
Year: 2013 PMID: 23795283 PMCID: PMC3686528 DOI: 10.1039/C3MD00021D
Source DB: PubMed Journal: Medchemcomm ISSN: 2040-2503 Impact factor: 3.597